Laatste proeven

EudraCT Number: 2004-001223-37

Sponsor Protocol Number: 102038

Start Date:

Sponsor Name: GlaxoSmithKline S.A.

Full Title: Ensayo clínico abierto en fase IV, para evaluar la inmunogenicidad y reactogenicidad de la vacuna combinada DTPa (Infanrix) de GlaxoSmithKline Biologicals administrada como dosis de recuerdo a los ...

Medical condition: Inmunización primaria activa frente a la difteria, tétanos y tosferina en niños, a partir de los 2 meses de edad hasta los 7 años.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: View results

EudraCT Number: 2005-003279-18

Sponsor Protocol Number: HLH-2004

Start Date:

Sponsor Name: Barncancerforskningsenheten, Astrid Lindgrens Barnsjukhus

Full Title: HLH-2004. Hemophagocytic Lymphohistiocytosis Study Group. Treatment Protocol of the Second International HLH Study 2004.

Medical condition: Hemophagocytic Lymphohistiocytosis (HLH), a life-threatening disease usually occurring in early childhood. HLH-2004 is an international treatment protocol which will be compared with the previous ...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: NO (Ongoing)

Trial results: (No results available)

EudraCT Number: 2014-000545-78

Sponsor Protocol Number: Rempex-505

Start Date:

Sponsor Name: Rempex Pharmaceuticals, Inc.

Full Title: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF CARBAVANCE™ (MEROPENEM/RPX7009) COMPARED TO PIPERACILLIN/TAZOBACTAM IN TH...

Medical condition: complicated urinary tract infection (cUTI) or acute pyelonephritis (AP) with or without concurrent bacteremia

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	10021881 - Infections and infestations	10037597	Pyelonephritis acute	PT
	18.0	10021881 - Infections and infestations	10046577	Urinary tract infections	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) CZ (Completed) SK (Completed) IT (Completed) ES (Completed) PL (Completed) SI (Completed) BG (Completed) GR (Completed)

Trial results: View results

EudraCT Number: 2009-017228-24

Sponsor Protocol Number: CMM/DM1

Start Date:

Sponsor Name: Instituto Científico y Tecnológico de Navarra

Full Title: Ensayo clínico de tratamiento de la Diabetes Mellitus tipo 1 autoinmune con células madre mesenquimales autólogas

Medical condition: Diatetes mellitus tipo 1 autoinmune

Disease:	Version	SOC Term	Classification Code	Term	Level
	13		10045228	Diabetes mellitus tipo I	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2010-023410-31

Sponsor Protocol Number: PLADSEL

Start Date:

Sponsor Name: CHU DE POITIERS

Full Title: Simplification du test de sensibilité au sel : étude préalable chez l'enfant et l'adulte

Medical condition: Hypertension artérielle

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10020775	Hypertension arterial	LLT

Population Age: Children, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-005571-10

Sponsor Protocol Number: 03-08-21-12

Start Date:

Sponsor Name: Kennedy Krieger Inst. Johns Hopkins Medicine

Full Title: DEXTROMETORPHAN IN RETT SYNDROME

Medical condition: Rett syndrome (RTT) is a neurological disorder with devastating consequences on the brain. It is characterized by stagnation of development followed by regression, both occurring between age 6 mont...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Female

Trial protocol: NO (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-003025-28

Sponsor Protocol Number: TUD-RELAX1-070

Start Date:

Sponsor Name: Technische Universität Dresden

Full Title: Phase-I/II trial for relapsed or refractory AML patients combining cytarabine and mitoxantrone with venetoclax

Medical condition: Patients 18-75 years with acute myeloid leukaemia (AML) at first or second relapse after intensive chemotherapy including allogeneic stem cell transplantation or primary refractory to standard indu...

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	100000004864	10000886	Acute myeloid leukemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2016-001955-29

Sponsor Protocol Number: 024PKAN15004

Start Date:

Sponsor Name: Retrophin, Inc.

Full Title: Efficacy, Safety, and Tolerability of Fosmetpantotenate (RE-024), a Phosphopantothenate replacement therapy, in patients with Pantothenate Kinase-associated Neurodegeneration (PKAN): A Randomized, ...

Medical condition: Pantothenate kinase associated neurodegeneration (PKAN), an autosomal recessive genetic disorder, the most common form of Neurodegeneration with Brain Iron Accumulation (NBIA). It is a progressive,...

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029205 - Nervous system disorders	10053643	Neurodegenerative disorder	PT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DE (Completed) ES (Prematurely Ended) GB (Prematurely Ended) CZ (Prematurely Ended) NO (Completed) FR (Completed) PL (Prematurely Ended) IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-015767-14

Sponsor Protocol Number: FER-FID-CHEMO

Start Date:

Sponsor Name: Vifor (International) AG

Full Title: A randomised controlled parallel group open-label study to evaluate the efficacy and safety of intravenous ferric carboxymaltose versus no treatment in anaemic subjects with lymphoid malignancies...

Medical condition: Anaemic subjects with lymphoid malignancies and functional iron deficiency receiving chemotherapy

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025631	Malignant lymphoid neoplasm NOS	LLT
	14.0	10005329 - Blood and lymphatic system disorders	10002034	Anaemia	PT
	14.0	10027433 - Metabolism and nutrition disorders	10022970	Iron deficiency	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) SE (Prematurely Ended) AT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2005-005702-23

Sponsor Protocol Number: BY217/M2-401

Start Date:

Sponsor Name: Nycomed GmbH

Full Title: Efficacy of 500µg roflumilast once daily versus placebo over 12 weeks in patients with diabetes mellitus type 2. A double blind, parallel group, phase IIb, proof of concept clinical study

Medical condition: Diabetes mellitus type 2

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

Laatste proeven

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies